Norton Waterford Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NORTON WATERFORD
NORTON WATERFORD has one approved drug.
There are seventeen US patents protecting NORTON WATERFORD drugs. There is one tentative approval on NORTON WATERFORD drugs.
There are two hundred and forty-one patent family members on NORTON WATERFORD drugs in twenty-seven countries.
Summary for Norton Waterford
| International Patents: | 241 |
| US Patents: | 17 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Norton Waterford
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | 8,132,712 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | Yes | 12,296,089 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | Yes | 10,695,512 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | 11,865,247 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | 11,559,637 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | 11,583,643 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Norton Waterford
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | 7,637,260 | ⤷ Start Trial |
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | 6,446,627 | ⤷ Start Trial |
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | 6,446,627 | ⤷ Start Trial |
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | 7,637,260 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Norton Waterford Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3998096 | ⤷ Start Trial |
| Japan | 2013526353 | ⤷ Start Trial |
| Australia | 2008234098 | ⤷ Start Trial |
| Cyprus | 1116092 | ⤷ Start Trial |
| Hungary | E042291 | ⤷ Start Trial |
| Israel | 247401 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
